Chaowei Ren

453 total citations
9 papers, 382 citations indexed

About

Chaowei Ren is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Chaowei Ren has authored 9 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Hematology and 5 papers in Oncology. Recurrent topics in Chaowei Ren's work include Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Chaowei Ren is often cited by papers focused on Protein Degradation and Inhibitors (9 papers), Ubiquitin and proteasome pathways (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Chaowei Ren collaborates with scholars based in China and United States. Chaowei Ren's co-authors include Xiaobao Yang, Biao Jiang, Renhong Sun, Jinju Chen, Ning Sun, Xing Qiu, Qianqian Yin, Ying Kong, Haixia Liu and Xiaoling Song and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Chaowei Ren

9 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chaowei Ren China	8	358	188	168	26	25	9	382
Xing Qiu China	10	361 1.0×	179 1.0×	131 0.8×	33 1.3×	30 1.2×	16	395
Aleša Bricelj Slovenia	8	433 1.2×	170 0.9×	155 0.9×	24 0.9×	32 1.3×	11	476
Inchul You United States	8	305 0.9×	129 0.7×	62 0.4×	32 1.2×	24 1.0×	11	351
John Houston United States	8	437 1.2×	233 1.2×	136 0.8×	66 2.5×	18 0.7×	12	487
Aleksas Matvekas United States	6	264 0.7×	102 0.5×	71 0.4×	46 1.8×	8 0.3×	7	307
Andrew Conroy United States	5	165 0.5×	124 0.7×	46 0.3×	31 1.2×	60 2.4×	12	255
Montserrat Pérez-Salvia Spain	5	251 0.7×	56 0.3×	64 0.4×	15 0.6×	8 0.3×	6	276
Hoda Metwally United States	7	292 0.8×	148 0.8×	92 0.5×	49 1.9×	11 0.4×	10	324
Alicia Harbin United States	2	392 1.1×	185 1.0×	100 0.6×	5 0.2×	10 0.4×	2	400
Osamu Ujikawa Japan	7	577 1.6×	238 1.3×	224 1.3×	26 1.0×	36 1.4×	7	615

Countries citing papers authored by Chaowei Ren

Since Specialization

Citations

This map shows the geographic impact of Chaowei Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaowei Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaowei Ren more than expected).

Fields of papers citing papers by Chaowei Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaowei Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaowei Ren. The network helps show where Chaowei Ren may publish in the future.

Co-authorship network of co-authors of Chaowei Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Chaowei Ren. A scholar is included among the top collaborators of Chaowei Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaowei Ren. Chaowei Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Sun, Renhong, Haixia Liu, Chaowei Ren, et al.. (2022). Design, synthesis and biological evaluation of novel quinazolinone derivatives as CRBN E3 ligase modulators. European Journal of Medicinal Chemistry. 247. 115016–115016. 3 indexed citations

Liu, Haixia, Xinyu Ding, Linyi Liu, et al.. (2022). Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor. European Journal of Medicinal Chemistry. 244. 114810–114810. 23 indexed citations

Liu, Haixia, Chaowei Ren, Renhong Sun, et al.. (2022). Reactive oxygen species-responsive Pre-PROTAC for tumor-specific protein degradation. Chemical Communications. 58(72). 10072–10075. 50 indexed citations

Ren, Chaowei, Ning Sun, Ying Kong, et al.. (2021). Structure-based discovery of SIAIS001 as an oral bioavailability ALK degrader constructed from Alectinib. European Journal of Medicinal Chemistry. 217. 113335–113335. 38 indexed citations

Liu, Haixia, Xinyu Ding, Linyi Liu, et al.. (2021). Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry. 223. 113645–113645. 42 indexed citations

Ren, Chaowei, Ning Sun, Haixia Liu, et al.. (2021). Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Metastasis-Related Oncoproteins and a Reshuffling Kinome Profile. Journal of Medicinal Chemistry. 64(13). 9152–9165. 32 indexed citations

Sun, Ning, Chaowei Ren, Ying Kong, et al.. (2020). Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance. European Journal of Medicinal Chemistry. 193. 112190–112190. 66 indexed citations

Liu, Haixia, Renhong Sun, Chaowei Ren, et al.. (2020). Construction of an IMiD-based azide library as a kit for PROTAC research. Organic & Biomolecular Chemistry. 19(1). 166–170. 24 indexed citations

Zhao, Quanju, Chaowei Ren, Linyi Liu, et al.. (2019). Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase. Journal of Medicinal Chemistry. 62(20). 9281–9298. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact